يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Teresa Boyea"', وقت الاستعلام: 1.45s تنقيح النتائج
  1. 1
    Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design

    المؤلفون: Xin Li, Jianke Li, Richard Molenkamp, Andre van Vliet, Christine J. Weegink, Daphne M. Hotho, Hans-Peter Guler, Joep de Bruijne, Harry L.A. Janssen, A. Marie O'Farrell, Teresa Boyea, Michele Bracken, Hendrik W. Reesink, Robert J. de Knegt, Jeroen van de Wetering de Rooij, Janke Schinkel, David Campbell

    المساهمون: AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and Hepatology, AII - Amsterdam institute for Infection and Immunity, Medical Microbiology and Infection Prevention, Gastroenterology & Hepatology, Hematology

    المصدر: Antiviral therapy, 17(2), 365-375. International Medical Press Ltd
    Antiviral Therapy, 17(2), 365-375. International Medical Press Ltd

    مصطلحات موضوعية: Adult, Male, Adolescent, Lactams, High selectivity, Hepacivirus, Pharmacology, Antiviral Agents, Young Adult, Double-Blind Method, Pharmacokinetics, SDG 3 - Good Health and Well-being, Humans, Medicine, Potency, Protease Inhibitors, Pharmacology (medical), Protease inhibitor (pharmacology), Replicon, Accelerated phase, Aged, business.industry, Middle Aged, Viral Load, Boronic Acids, Hepatitis C, Virology, Infectious Diseases, Hcv protease, RNA, Viral, Female, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4536e7309611d74c0d1d4394da0c6d
    https://pure.eur.nl/en/publications/30b87d3c-5c66-4068-9ee3-f0fb85cebe5a

    أضف إلى المفضلة
  2. 2
    Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients

    المؤلفون: Kirsti Klemm, Sherwyn Schwartz, Julie M. Cherrington, Hans-Peter Guler, Jianke Li, Teresa Boyea, A. Marie O'Farrell

    المصدر: Current Medical Research and Opinion. 26:2003-2010

    مصطلحات موضوعية: Adult, Male, Dipeptidyl Peptidase 4, Administration, Oral, Pharmacology, law.invention, Randomized controlled trial, Pharmacokinetics, law, Diabetes mellitus, medicine, Humans, Hypoglycemic Agents, Drug Interactions, Aged, Dipeptidyl-Peptidase IV Inhibitors, Cross-Over Studies, business.industry, General Medicine, Middle Aged, medicine.disease, Boronic Acids, Crossover study, Metformin, Diabetes Mellitus, Type 2, Tolerability, Pharmacodynamics, Concomitant, Drug Therapy, Combination, Female, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb9ce6200958727f75ccd1f0adf9ae1
    https://doi.org/10.1185/03007995.2010.491266

    PDF full text from Publisher
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.

    المؤلفون: Jianke Li, Kirsti Klemm, A. Marie O'Farrell, Hans-Peter Guler, Julie M. Cherrington, Sherwyn Schwartz, Teresa Boyea

    المصدر: Current Medical Research & Opinion; Jan2010, Vol. 26 Issue 8, p2003-2010, 8p

    مصطلحات موضوعية: TYPE 2 diabetes treatment, PHARMACOKINETICS, PHARMACODYNAMICS, METFORMIN, CD26 antigen, ORAL therapy for diabetes

    PDF full text from Publisher
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء